Updated recommendations for treating, preventing HIV infection

Bottom Line: A volunteer panel of experts in HIV research and patient care evaluated new data and treatments to update recommendations from the International Antiviral Society-USA for the use of antiretroviral drugs in this special communication article. The updated recommendations encompass initiating therapy, monitoring individuals starting therapy, changing regimens and preventing HIV infection for individuals at risk. Advances in the prevention and treatment of HIV continue to improve clinical management and outcomes for patients with HIV and those at risk. A two-part podcast on the history of AIDS accompanies this article, as well as other related articles listed below.

Authors: Michael S. Saag, M.D., University of Alabama at Birmingham, and coauthors

Related material:

The first episode of a two-part podcast on the history of AIDS, "Working on the Precipice: On the Frontlines of the AIDS Epidemic at the CDC, Part I," is available to preview on the For The Media website. The second episode will be live at 11 a.m. ET on August 1.

A promo of the podcast is available for immediate use. Coming next week (July 24) to the JAMA Clinical Reviews #podcast: JAMA Deputy Editor Ed Livingston embarks on a two-part look at the #CDC clinicians on the frontlines of the emerging #AIDS crisis in the 80s.

The editorial, "2018 IAS-USA Recommendations for the Use of Antiretroviral Therapy for HIV," by James Riddell IV, M.D., University of Michigan Medical Center, Ann Arbor, is available on the For The Media website.

– A JAMA article and accompanying podcast, "Anthony Fauci, M.D.: Working to End HIV/AIDS," are available here and here. A Viewpoint article by Dr. Fauci, "An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic," is available here.

To Learn More: The full report is available on the For The Media website.

(doi:10.1001/jama.2018.8431)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Want to embed a link to this report in your story? Link will be live at the embargo time: http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.8431

Media Contact

Savannah Koplon
[email protected]

@JAMA_current

Comments